Answers are grounded in this paper and cite their sources.
The LuxS enzyme participates in bacterial metabolism and produces the precursor of autoinducer-2 (AI-2), a signaling molecule implicated in bacterial stress responses and genetic competence. Although LuxS/AI-2 has been associated with antibiotic responses in other streptococci, its contribution to antibiotic susceptibility in Streptococcus pneumoniae remains poorly understood. Here, we investigated the role of LuxS in pneumococcal survival during exposure to erythromycin and ampicillin and examined whether supplementation with 4,5-dihydroxy-2,3-pentanedione (DPD), the precursor of AI-2, could alleviate the effects of luxS inactivation. The ΔluxS mutant exhibited significantly greater reductions in viable cell counts than the wild type following antibiotic exposure, even after accounting for differences in baseline growth. Supplementation with 50 nM DPD significantly improved mutant survival during exposure to both antibiotics. We further investigated the contribution of LuxS/AI-2 to genetic competence, a phenotype previously associated with luxS inactivation. The mutant exhibited reduced transformation efficiency, which was significantly improved by DPD supplementation, although recovery remained partial. Together, these findings provide evidence that LuxS contributes to pneumococcal survival during antibiotic exposure and demonstrate that exogenous DPD can partially compensate for the effects of luxS inactivation on antibiotic responses and genetic transformation. These results extend our understanding of LuxS/AI-2-associated phenotypes in S. pneumoniae.
No takes yet. Share an insight, caveat, or question.
Salvadori et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: